Trade Summary

1 month ago, Patel Snehal, serving as CEO, CFO, 10% owner at Greenwich Lifesciences, Inc. (GLSI), purchased 4,600 shares at $8.37 per share, for a total transaction value of $38,502.00. Following this transaction, Patel Snehal now holds 5,588,102 shares of GLSI.

The trade was executed on Tuesday, November 25, 2025 and publicly disclosed via SEC Form 4 filing on Friday, November 28, 2025, 3 days after the trade was made.

Greenwich Lifesciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.